Data |
Ora |
Fonte |
Titolo |
19/12/2024 | 17:26 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
18/12/2024 | 16:31 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
10/12/2024 | 18:16 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
10/12/2024 | 18:12 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
09/12/2024 | 13:29 | ALNC | MaxCyte ups core revenue guidance for 2024 as eyes 2025 cost.. |
09/12/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. MaxCyte Streamlines Operations and Raises.. |
09/12/2024 | 08:00 | GLOBE | MaxCyte Announces Streamlined Operations and Raises 2024.. |
02/12/2024 | 18:09 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights and Block Listing Return |
28/11/2024 | 16:05 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
28/11/2024 | 16:05 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
19/11/2024 | 10:49 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
13/11/2024 | 14:05 | GLOBE | MaxCyte Celebrates 25 Years of Innovation Driving Cell.. |
08/11/2024 | 15:41 | ALNC | MaxCyte third-quarter profit falls amid surging costs |
07/11/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Filing of 10Q form |
07/11/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Third Quarter 2024 Financial Results |
06/11/2024 | 22:05 | GLOBE | MaxCyte Reports Third Quarter 2024 Financial Results and.. |
06/11/2024 | 22:05 | UKREG | MaxCyte Reports Third Quarter 2024 Financial Results and.. |
06/11/2024 | 14:43 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
04/11/2024 | 14:23 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights |
31/10/2024 | 13:05 | GLOBE | MaxCyte to Participate in Two Upcoming Investor Conferences |
31/10/2024 | 13:05 | LSEG_NON | MaxCyte, Inc. Upcoming Investor Conferences |
31/10/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
18/10/2024 | 10:24 | LSEG_RNS | MaxCyte, Inc. Grant of Options and Restricted Stock Units |
15/10/2024 | 14:05 | LSEG_RNS | MaxCyte, Inc. MaxCyte Appoints Cynthia Collins to Board |
15/10/2024 | 14:05 | GLOBE | MaxCyte Appoints Cynthia Collins to its Board of Directors |
11/10/2024 | 14:05 | GLOBE | MaxCyte to Report Third Quarter 2024 Financial Results on.. |
11/10/2024 | 14:00 | LSEG_RNS | MaxCyte, Inc. Notice of Results |
10/10/2024 | 14:05 | LSEG_RNS | MaxCyte, Inc. MaxCyte Appoints Ali Soleymannezhad as CCO |
10/10/2024 | 14:05 | GLOBE | MaxCyte Appoints Ali Soleymannezhad as Chief Commercial.. |
03/10/2024 | 10:41 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
01/10/2024 | 10:47 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
01/10/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights |
27/9/2024 | 17:15 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
27/9/2024 | 16:29 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
20/9/2024 | 18:02 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
16/9/2024 | 11:33 | ALNC | MaxCyte touts strategic platform license deal with Kamau.. |
16/9/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
16/9/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Signing of Strategic Platform License |
16/9/2024 | 08:00 | GLOBE | MaxCyte Signs Strategic Platform License with Kamau.. |
06/9/2024 | 18:07 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
06/9/2024 | 12:33 | LSEG_NON | MaxCyte, Inc. Bioprocessing Conference Participation |
05/9/2024 | 22:05 | GLOBE | MaxCyte to Participate in Virtual Craig-Hallum Capital Group.. |
03/9/2024 | 16:38 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights |
29/8/2024 | 11:06 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
07/8/2024 | 15:10 | ALNC | MaxCyte reaffirms guidance as revenue jumps 24% in first.. |
07/8/2024 | 08:05 | LSEG_RNS | MaxCyte, Inc. Filing of Form 10-Q |
07/8/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Second Quarter and Half-Year Results |
06/8/2024 | 22:05 | GLOBE | MaxCyte Reports Second Quarter and Half-Year 2024 Financial.. |
01/8/2024 | 17:31 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights |
31/7/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |